AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-27624690_ITM" title="Facts and information about VALUE Trial to Determine the Efficacy of Diovan(R) in Reducing Cardiovascular Organ Damage and Death.">VALUE Trial to Determine the Efficacy of Diovan(R) in Reducing Cardiovascular Organ Damage and Death.</a>

Close Set up an RSS feed that alerts you when new articles from PR Newswire are available.

Frequently asked questions about RSS feeds

VALUE Trial to Determine the Efficacy of Diovan(R) in Reducing Cardiovascular Organ Damage and Death.

PR Newswire

| April 07, 2000 | COPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

- Largest ARB study may provide new cardiac risk-factor assessment tool -

EAST HANOVER, N.J., Feb. 29 /PRNewswire/ --

The VALUE Trial (Valsartan Antihypertensive Long-term Use Evaluation), one of the largest, most far-reaching trials undertaken of a cardiovascular treatment, has more than met its goal by enrolling 15,300 patients at approximately 1,000 centers in 32 nations, one of the leading investigators of the Diovan(R) (valsartan) study announced today.

"The angiotensin II receptor blocker (ARB) Diovan is well-established as an effective agent to control hypertension," said Dr. Stevo Julius, Professor of Medicine and Physiology, University of Michigan Medical Center, and a lead…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


THE VALUE TRIAL COMPLEMENTS THE LONG-TERM CARDIOPROTECTIVE PROFILE OF DIOVAN.: News wire article from: ANT - LKBN ANTARA (Indonesia) June 15, 2004 700+ words
...control, whether a Diovan-based treatment regimen...risk patients. The VALUE trial complements the long...cardioprotective profile of Diovan and suggests potential...than they did in the Diovan group (13.4%; p...significant). While the VALUE trial demonstrated better...


The VALUE Trial Complements the Long-Term Cardioprotective Profile of Diovan.: Press release article from: PR Newswire June 14, 2004 700+ words
...control, whether a Diovan-based treatment regimen...risk patients. The VALUE trial complements the long...cardioprotective profile of Diovan and suggests potential...than they did in the Diovan group (13.4%; p...significant). While the VALUE trial demonstrated better...


Novartis Initiates First Clinical Trial Comparing the Effects of Diovan(TM)...: Press release article from: PR Newswire October 1, 1997 700+ words
...announced the initiation of the DioVan Antihypertensive Long-term Use Evaluation (VALUE) trial, a major, multinational...long-term benefits of Diovan(TM) (valsartan), an...hypothesis is that the ARB Diovan will be more efficacious...


New data demonstrate benefits of Diovan in reducing life-threatening...: News wire article from: Europe Intelligence Wire September 5, 2005 700+ words
...HeFT examining the protective benefits of Diovan for people with heart failure is also being...today.[vii] Further protective effects of Diovan have also been shown in the VALUE trial, where Diovan prevented the development of new onset diabetes...


New data reinforce powerful blood pressure-lowering efficacy with...: News wire article from: Europe Intelligence Wire June 20, 2005 700+ words
...combination with HCTZ as Co-Diovan[R] (valsartan and HCTZ...treated with a combination of Diovan and HCTZ (160/25) benefited...addition, two new analyses of the VALUE trial demonstrated that Diovan may reduce the development of...


Novartis Announces Major Mortality Trial Investigating Diovan(R)(Valsartan) in...: Press release article from: PR Newswire August 24, 1998 700+ words
...may lead to new indications for Diovan." The VALIANT trial is being...years. The clinical program for Diovan is the largest declared morbidity...Long-term Use Evaluation (VALUE) trial is comparing Diovan with the calcium channel


TRIAL COMPLEMENTS LONG-TERM CARDIOPROTECTIVE PROFILE OF DIOVAN.: News wire article from: AsiaPulse News June 15, 2004 700+ words
...control, whether a Diovan-based treatment regimen...risk patients. The VALUE trial complements the long...cardioprotective profile of Diovan and suggests potential...than they did in the Diovan group (13.4 per cent...significant). While the VALUE trial demonstrated better...


New Study Shows Diovan(R) (Valsartan) Reduces Left Ventricular Hypertrophy;...: Press release article from: PR Newswire November 10, 1998 700+ words
...the potential benefits of the Diovan mechanism of action across...infarction and diabetes." The Diovan clinical trial program includes...Long-Term Use Evaluation (VALUE) trial involving approximately 14...recently suffered a heart attack. Diovan is also being studied in patients...


Diovan controls isolated systolic hypertension in elderly patients.: Newspaper article from: Cardiovascular Week June 9, 2003 700+ words
...observed in 74.7% of Diovan patients vs. 73.0% of amlodipine patients. While Diovan and amlodipine were equally...pressure, patients taking Diovan were five times less likely...pressure patients. The VALUE trial compares cardiovascular...


Diovan Controls Isolated Systolic Hypertension In Elderly Patients, New Study...: Press release article from: PR Newswire May 14, 2003 700+ words
...observed in 74.7% of Diovan patients vs. 73.0% of amlodipine patients. While Diovan and amlodipine were equally...pressure, patients taking Diovan were five times less likely...pressure patients. The VALUE trial compares cardiovascular...

For more facts and information, see all results

Source: HighBeam Research, VALUE Trial to Determine the Efficacy of Diovan(R) in Reducing...

The AccessMyLibrary advertising network includes: